• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New insights on portal hypertension's screening in people with cystic fibrosis.

作者信息

Colecchia Luigi, Ravaioli Federico, Marasco Giovanni, Dajti Elton, Colecchia Antonio

机构信息

Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.

Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, Bern, Switzerland.

出版信息

Hepatobiliary Surg Nutr. 2024 Oct 1;13(5):894-897. doi: 10.21037/hbsn-24-467. Epub 2024 Sep 26.

DOI:10.21037/hbsn-24-467
PMID:39507743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11534791/
Abstract
摘要

相似文献

1
New insights on portal hypertension's screening in people with cystic fibrosis.关于囊性纤维化患者门静脉高压筛查的新见解。
Hepatobiliary Surg Nutr. 2024 Oct 1;13(5):894-897. doi: 10.21037/hbsn-24-467. Epub 2024 Sep 26.
2
Splenic-hepatic elastography index is useful in differentiating between porto-sinusoidal vascular disease and cirrhosis in patients with portal hypertension.脾-肝弹性成像指数有助于区分门静脉高压症患者的门脉窦性血管病和肝硬化。
Dig Liver Dis. 2023 Jan;55(1):75-80. doi: 10.1016/j.dld.2022.09.018. Epub 2022 Oct 22.
3
Link between persistent, unexplained gamma-glutamyltransferase elevation and porto-sinusoidal vascular disorder.持续性不明原因γ-谷氨酰转移酶升高与门-肝窦血管疾病之间的关联。
JHEP Rep. 2024 Jun 23;6(9):101150. doi: 10.1016/j.jhepr.2024.101150. eCollection 2024 Sep.
4
The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.囊性纤维化患者肝脏受累的非侵入性评估：一项前瞻性研究。
Liver Int. 2023 Nov;43(11):2492-2502. doi: 10.1111/liv.15748. Epub 2023 Sep 19.
5
Porto-sinusoidal vascular disorder.窦周隙血管障碍。
J Hepatol. 2022 Oct;77(4):1124-1135. doi: 10.1016/j.jhep.2022.05.033. Epub 2022 Jun 9.
6
A Case of Porto-Sinusoidal Vascular Disease.一例门静脉窦状血管疾病病例。
Eur J Case Rep Intern Med. 2023 Oct 30;10(12):004138. doi: 10.12890/2023_004138. eCollection 2023.
7
Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension.瞬时弹性成像检测肝硬度诊断伴有门静脉高压的门腔静脉血管性肝病。
Hepatology. 2021 Jul;74(1):364-378. doi: 10.1002/hep.31688. Epub 2021 Jun 11.
8
Diagnostic performance of transient elastography in differentiation between porto-sinusoidal vascular liver disease and compensated cirrhosis.瞬时弹性成像在肝窦状隙血管性肝病与代偿期肝硬化鉴别诊断中的性能
Liver Int. 2023 Nov;43(11):2513-2522. doi: 10.1111/liv.15709. Epub 2023 Aug 24.
9
Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease.非肝硬化门静脉高压症——门静脉窦状血管疾病的诊断挑战
World J Gastroenterol. 2020 Jun 14;26(22):3000-3011. doi: 10.3748/wjg.v26.i22.3000.
10
Porto-sinusoidal Vascular Disease and Portal Hypertension.窦前性门静脉血管病和门静脉高压症。
Clin Liver Dis. 2024 Aug;28(3):455-466. doi: 10.1016/j.cld.2024.03.004. Epub 2024 May 1.

本文引用的文献

1
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder.脾硬度测量在排除门静脉窦状血管疾病患者高危静脉曲张中的应用
Hepatology. 2025 Feb 1;81(2):546-559. doi: 10.1097/HEP.0000000000001004. Epub 2024 Jul 2.
2
Single-cell RNA sequencing of cystic fibrosis liver disease explants reveals endothelial complement activation.单细胞 RNA 测序对囊性纤维化肝病植体的研究揭示了内皮细胞补体的激活。
Liver Int. 2024 Sep;44(9):2382-2395. doi: 10.1111/liv.15963. Epub 2024 Jun 7.
3
Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.肠道菌群失调在小鼠囊性纤维化相关性肝病发病机制中的突出作用。
J Hepatol. 2024 Sep;81(3):429-440. doi: 10.1016/j.jhep.2024.03.041. Epub 2024 Mar 28.
4
Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesis.严重囊性纤维化肝病的遗传变异与疾病发病机制的新机制有关。
Hepatology. 2024 Nov 1;80(5):1012-1025. doi: 10.1097/HEP.0000000000000863. Epub 2024 Mar 27.
5
Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools.使用肝纤维化评估工具改善囊性纤维化相关肝病的检测
Heliyon. 2023 Nov 7;9(11):e21861. doi: 10.1016/j.heliyon.2023.e21861. eCollection 2023 Nov.
6
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.囊性纤维化肝胆道疾病筛查、评估和管理的共识建议。
Hepatology. 2024 May 1;79(5):1220-1238. doi: 10.1097/HEP.0000000000000646. Epub 2023 Oct 26.
7
The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.囊性纤维化患者肝脏受累的非侵入性评估：一项前瞻性研究。
Liver Int. 2023 Nov;43(11):2492-2502. doi: 10.1111/liv.15748. Epub 2023 Sep 19.
8
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis.脾脏硬度测量对代偿期晚期慢性肝病患者临床显著性门静脉高压诊断的准确性：一项系统评价和个体患者数据荟萃分析
Lancet Gastroenterol Hepatol. 2023 Sep;8(9):816-828. doi: 10.1016/S2468-1253(23)00150-4. Epub 2023 Jul 18.
9
Baveno VII - Renewing consensus in portal hypertension.《巴韦诺 VII 共识：门静脉高压领域的新共识》
J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30.
10
Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis.综述文章：囊性纤维化成人肝病的流行病学、发病机制和治疗。
Aliment Pharmacol Ther. 2022 Feb;55(4):389-400. doi: 10.1111/apt.16749. Epub 2022 Jan 19.